Skip to main content
. 2016 Jun 29;52(2):218–228. doi: 10.1007/s00535-016-1230-0

Fig. 2.

Fig. 2

Comparison of the diagnostic power of biliary cytology, WFA-sialylated MUC1 (WFA-MUC1), and CA19-9 among all patients with biliary tract carcinoma or intrahepatic cholangiocarcinoma (CC), patients with perihilar CC or intrahepatic CC, those with distal CC, and those with gallbladder carcinoma